Pharmaceutical

Bavarian Nordic nets $160m from priority review voucher sale

Bavarian Nordic has sold a PRV for $160m, a day after the FDA announced a new scheme utilising the fast-track tickets.

Jun 19, 2025 - 06:00
Bavarian Nordic nets $160m from priority review voucher sale
Bavarian Nordic has sold a PRV for $160m, a day after the FDA announced a new scheme utilising the fast-track tickets.
Read the original article

Tags:

Previous Article

NHS England chair suggests England can learn from European health schemes

Next Article

Tisento’s MELAS treatment receives fast track status from FDA

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: UPenn and St. Luke’s have withdrawn from US News’ best hospitals list. Will others follow?

STAT+: UPenn and St. Luke’s have withdrawn from US News...

Jul 6, 2023

EMA CHMP supports CStone’s sugemalimab for metastatic NSCLC

EMA CHMP supports CStone’s sugemalimab for metastatic N...

Jun 4, 2024

Engineering the future: how robotics and automation are transforming pharmaceutical logistics

Engineering the future: how robotics and automation are...

May 16, 2025